Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro is not licensed specifically for PCOS, and the NHS does not prescribe it for that condition. For NHS access to Mounjaro, the licensed indication is weight management — and eligibility depends on BMI thresholds and weight-related comorbidities, not a PCOS diagnosis on its own. That said, PCOS is a weight-related condition that can count towards private eligibility, and many women with PCOS find that tirzepatide significantly affects the metabolic symptoms that make PCOS so difficult to manage. Whether the NHS route is open to you, or whether a private prescription makes more sense, comes down to where your numbers sit and what a prescriber concludes after a proper clinical assessment — which is the only legal route to this prescription-only medicine.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
No. The NHS prescribes Mounjaro under NICE technology appraisal TA1026, which covers weight management in adults with obesity, not PCOS as a stand-alone diagnosis. To qualify on the NHS right now, you generally need a BMI of 40 or above and four or more of five specified conditions: high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, or type 2 diabetes. From around June 2026, the second NHS cohort opened access at BMI 35 to 39.9 with four or more of those same conditions. PCOS does not appear on that qualifying list, and a PCOS diagnosis on its own does not meet the NHS threshold.
So if your GP knows you have PCOS and thinks Mounjaro might help, they cannot simply prescribe it for you on the NHS on those grounds. The prescription has to follow the commissioned pathway, which is rooted in BMI and specific comorbidities. Our page on Mounjaro and NHS access sets out the full phased eligibility picture if you want the detail.
Yes, it can, though BMI still has to stack up alongside it. Private eligibility follows the medicine's licensed indication rather than NHS commissioning criteria. Mounjaro's UK licence covers adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition. PCOS is recognised as a weight-related condition under UK guidance, so for someone sitting at a BMI between 27 and 29.9, a confirmed PCOS diagnosis can make the difference between qualifying and not.
BMI alone does not guarantee a prescription, though. A prescriber weighs up the full clinical picture, medical history, current medications, contraindications, and whether the benefits outweigh the risks for you specifically. Anyone on oral contraceptives should also know that tirzepatide can reduce pill absorption in the first four weeks of treatment and after each dose increase, so an additional non-oral contraceptive method is advised during those windows. That is a practical thing to raise at consultation, especially given that many women with PCOS use the pill to regulate cycles.
If you are trying to conceive, Mounjaro is not recommended. The medicine should be stopped before attempting pregnancy, and your prescriber will discuss the appropriate wash-out period with you.
The SURMOUNT clinical programme, which involved thousands of adults with obesity, showed average body-weight reductions of around 20% at the 15mg dose over 72 weeks, data cited in NICE TA1026 and published in the New England Journal of Medicine. Weight loss at that scale tends to improve insulin resistance, androgen levels and menstrual regularity in women with PCOS, because excess adipose tissue drives much of the hormonal disruption that underlies the condition.
What the evidence does not yet show is a large, dedicated randomised trial of tirzepatide in women with PCOS specifically. Smaller studies and real-world reports are encouraging, but the robust PCOS-specific data set does not yet exist. That uncertainty is worth being honest about. If your endocrinologist or gynaecologist is involved in managing your PCOS, it is worth looping them in before starting any new weight-management medicine, because the interaction between GLP-1 medicines and PCOS-related treatments is still an area of active clinical interest.
Start by working out whether the NHS route is realistically open to you. Check your BMI and whether you meet the current cohort criteria, our guide to getting Mounjaro through your GP explains what to ask at your practice and how GP prescribing under the new contract actually works in practice. Many GP practices are still setting up their processes, so availability varies.
If you do not meet NHS criteria, or you do not want to wait, a private prescription is a legal, clinically supervised alternative, and our Mounjaro for sale page shows you exactly what is currently in stock and how to get started. At nume, a real prescriber (not a piece of software) reads your consultation the same day and reaches a clinical decision. Order before 12pm on a weekday and, if approved, your treatment leaves our GPhC-registered pharmacy the same day, arriving with DPD the next working day in plain packaging. The consultation is free, and the price shown on our treatment page covers everything: the prescription, delivery, and seven-day aftercare support. No subscriptions, no repeat charges without another clinical review.
If you want to read about what private Mounjaro typically costs before deciding, or understand more about where to buy it safely, both pages will give you a grounded picture of what to expect. The MHRA has warned repeatedly about counterfeit pens sold through social media and unverified websites; always verify any online pharmacy on the GPhC register before handing over a prescription or payment.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.